Literature DB >> 7062186

Sustained-release theophylline: a significant advance in the treatment of childhood asthma.

E Tabachnik, P Scott, J Correia, A Isles, S MacLeod, C Newth, H Levison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7062186     DOI： 10.1016/s0022-3476(82)80467-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  Chest diseases-important advances in clinical medicine: management of childhood asthma.

Authors:  C D Lew; A C Platzker
Journal:  West J Med       Date:  1984-01

2.  Trends in the hospitalization for acute childhood asthma, 1970-84.

Authors:  N Halfon; P W Newacheck
Journal:  Am J Public Health       Date:  1986-11       Impact factor: 9.308

Review 3.  Acute overdose with sustained release drug formulations. Perspectives in treatment.

Authors:  A Minocha; D A Spyker
Journal:  Med Toxicol       Date:  1986 Jul-Aug

4.  Once a day theophylline; serum concentrations.

Authors:  V Nerminathan; S A McKenzie
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

5.  A once daily theophylline preparation in prevention of nocturnal symptoms in childhood asthma.

Authors:  B Bose; J I Cater; R A Clark
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

6.  Comparison of the in vitro dissolution properties and in vivo steady-state pharmacokinetics of two sustained-release theophylline preparations.

Authors:  J H Jonkman; W J Van der Boon; G Grasmeijer
Journal:  Pharm Weekbl Sci       Date:  1988-02-19

Review 7.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

8.  Control of severe pain with sustained-release morphine tablets v. oral morphine solution.

Authors:  W W Arkinstall; B R Goughnour; J A White; J H Stewart
Journal:  CMAJ       Date:  1989-03-15       Impact factor: 8.262
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.